최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Biomaterials, v.33 no.17, 2012년, pp.4251 - 4263
Lee, Sang-Soo (Infectious Disease Medical Research Center & Department of Pharmacology, College of Medicine, Hallym University, Chucheon, Gangwon-do 200-702, Republic of Korea) , Sharma, Ashish R. (Infectious Disease Medical Research Center & Department of Pharmacology, College of Medicine, Hallym University, Chucheon, Gangwon-do 200-702, Republic of Korea) , Choi, Byung-Soo (Infectious Disease Medical Research Center & Department of Pharmacology, College of Medicine, Hallym University, Chucheon, Gangwon-do 200-702, Republic of Korea) , Jung, Jun-Sub (Infectious Disease Medical Research Center & Department of Pharmacology, College of Medicine, Hallym University, Chucheon, Gangwon-do 200-702, Republic of Korea) , Chang, Jun-Dong (Institute for Skeletal Aging & Orthopaedic Surgery, Chuncheon Sacred Heart Hospital, College of Medicine, Hallym University, Chucheon, Republic of Korea) , Park, Seonghun (Institute for Skeletal Aging & Orthopaedic Surgery, Chuncheon Sacred Heart Hospital, College of Medicine, Hallym University, Chucheon, Republic of Korea) , Salvati, Eduardo A. (Orthopedic Surgery & Osteolysis Resear) , Purdue, Edward P. , Song, Dong-Keun , Nam, Ju-Suk
AbstractWear particles are the major cause of osteolysis associated with failure of implant following total joint replacement. During this pathologic process, activated macrophages mediate inflammatory responses to increase osteoclastogenesis, leading to enhanced bone resorption. In osteolysis cause...
Clin Orthop Relat Res Harris 46 1995 The problem is osteolysis
Instr Course Lect Friedman 43 233 1994 Current concepts in orthopaedic biomaterials and implant fixation
Arthritis Res Ther Abu-Amer 9 Suppl. 1 S6 2007 10.1186/ar2170 Aseptic loosening of total joint replacements: mechanisms underlying osteolysis and potential therapies
HSS J Purdue 2 102 2006 10.1007/s11420-006-9003-6 The central role of wear debris in periprosthetic osteolysis
Calcif Tissue Int Horowitz 59 392 1996 10.1007/s002239900145 Inflammatory response to implant particulates in a macrophage/osteoblast coculture model
Physiol Res Gallo 57 339 2008 10.33549/physiolres.931140 Bone remodeling, particle disease and individual susceptibility to periprosthetic osteolysis
J Orthop Res Horowitz 15 50 1997 10.1002/jor.1100150108 Effects of polyethylene on macrophages
J Biomed Mater Res Horowitz 41 468 1998 10.1002/(SICI)1097-4636(19980905)41:3<468::AID-JBM17>3.0.CO;2-E The effects of cobalt chromium upon macrophages
J Arthroplasty Vermes 16 95 2001 10.1054/arth.2001.28719 The potential role of the osteoblast in the development of periprosthetic osteolysis: review of in vitro osteoblast responses to wear debris, corrosion products, and cytokines and growth factors
Nat Med Goldring 13 133 2007 10.1038/nm0207-133 Eating bone or adding it: the Wnt pathway decides
Endocr Rev Yamaguchi 21 393 2000 10.1210/edrv.21.4.0403 Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfa1
Blood Pinzone 113 517 2009 10.1182/blood-2008-03-145169 The role of Dickkopf-1 in bone development, homeostasis, and disease
Rev Endocr Metab Disord Gazzerro 7 51 2006 10.1007/s11154-006-9000-6 Bone morphogenetic proteins and their antagonists
J Cell Biochem Mbalaviele 94 403 2005 10.1002/jcb.20253 Beta-catenin and BMP-2 synergize to promote osteoblast differentiation and new bone formation
Nat Med Diarra 13 156 2007 10.1038/nm1538 Dickkopf-1 is a master regulator of joint remodeling
Curr Opin Rheumatol Baker-LePain 23 389 2011 10.1097/BOR.0b013e3283474dbe Effects of inflammation on bone: an update
J Arthroplasty Buly 7 315 1992 10.1016/0883-5403(92)90056-V Titanium wear debris in failed cemented total hip arthroplasty. An analysis of 71 cases
Biomaterials Valles 27 5199 2006 10.1016/j.biomaterials.2006.05.045 Differential inflammatory macrophage response to rutile and titanium particles
J Biomed Mater Res A Valles 84 324 2008 10.1002/jbm.a.31315 Rutile and titanium particles differentially affect the production of osteoblastic local factors
Biomaterials Lee 32 9197 2011 10.1016/j.biomaterials.2011.08.059 Actin and ERK1/2-CEBPbeta signaling mediates phagocytosis-induced innate immune response of osteoprogenitor cells
Biomaterials Valles 29 2326 2008 10.1016/j.biomaterials.2008.02.011 Modulation of the cross-talk between macrophages and osteoblasts by titanium-based particles
Instr Course Lect Maloney 45 171 1996 Periprosthetic osteolysis in total hip arthroplasty: the role of particulate wear debris
Arthritis Rheum Hilal 41 891 1998 10.1002/1529-0131(199805)41:5<891::AID-ART17>3.0.CO;2-X Osteoblast-like cells from human subchondral osteoarthritic bone demonstrate an altered phenotype in vitro: possible role in subchondral bone sclerosis
J Cell Biochem Blum 80 532 2001 10.1002/1097-4644(20010315)80:4<532::AID-JCB1007>3.0.CO;2-B An optimized method for the chemiluminescent detection of alkaline phosphatase levels during osteodifferentiation by bone morphogenetic protein 2
Oral Dis Katagiri 8 147 2002 10.1034/j.1601-0825.2002.01829.x Regulatory mechanisms of osteoblast and osteoclast differentiation
Annu Rev Cell Dev Biol Capdevila 17 87 2001 10.1146/annurev.cellbio.17.1.87 Patterning mechanisms controlling vertebrate limb development
Bull NYU Hosp Jt Dis Hallab 67 182 2009 Biologic effects of implant debris
Am J Physiol Endocrinol Metab Hikiji 278 E1031 2000 10.1152/ajpendo.2000.278.6.E1031 Peroxynitrite production by TNF-alpha and IL-1beta: implication for suppression of osteoblastic differentiation
Endocrinology Gilbert 141 3956 2000 10.1210/endo.141.11.7739 Inhibition of osteoblast differentiation by tumor necrosis factor-alpha
J Biomed Mater Res A Fellah 93 1588 2010 10.1002/jbm.a.32663 Macrophage and osteoblast responses to biphasic calcium phosphate microparticles
Cells Tissues Organs Gerstenfeld 169 285 2001 10.1159/000047893 Impaired intramembranous bone formation during bone repair in the absence of tumor necrosis factor-alpha signaling
Cold Spring Harb Perspect Biol Oeckinghaus 1 a000034 2009 10.1101/cshperspect.a000034 The NF-kappaB family of transcription factors and its regulation
Cell Prolif Huang 44 420 2011 10.1111/j.1365-2184.2011.00769.x Dose-specific effects of tumor necrosis factor alpha on osteogenic differentiation of mesenchymal stem cells
Genome Biol Miller 3 2002 The Wnts
Annu Rev Cell Dev Biol Wodarz 14 59 1998 10.1146/annurev.cellbio.14.1.59 Mechanisms of Wnt signaling in development
Endocr Rev Canalis 24 218 2003 10.1210/er.2002-0023 Bone morphogenetic proteins, their antagonists, and the skeleton
J Biol Chem Lintern 284 23159 2009 10.1074/jbc.M109.025478 Characterization of wise protein and its molecular mechanism to interact with both Wnt and BMP signals
J Bone Miner Res Vincent 24 1434 2009 10.1359/jbmr.090305 Pro-inflammatory cytokines TNF-related weak inducer of apoptosis (TWEAK) and TNFalpha induce the mitogen-activated protein kinase (MAPK)-dependent expression of sclerostin in human osteoblasts
Biochem Biophys Res Commun Yamamoto 238 574 1997 10.1006/bbrc.1997.7325 Smad1 and smad5 act downstream of intracellular signalings of BMP-2 that inhibits myogenic differentiation and induces osteoblast differentiation in C2C12 myoblasts
Dev Biol Collette 342 169 2010 10.1016/j.ydbio.2010.03.021 Genetic evidence that SOST inhibits WNT signaling in the limb
J Biol Chem Kusu 278 24113 2003 10.1074/jbc.M301716200 Sclerostin is a novel secreted osteoclast-derived bone morphogenetic protein antagonist with unique ligand specificity
J Am Acad Orthop Surg Tuan 16 Suppl. 1 S42 2008 10.5435/00124635-200800001-00010 What are the local and systemic biologic reactions and mediators to wear debris, and what host factors determine or modulate the biologic response to wear particles?
Ann N Y Acad Sci Seo 1117 151 2007 10.1196/annals.1402.027 ERK signaling regulates macrophage colony-stimulating factor expression induced by titanium particles in MC3T3.E1 murine calvarial preosteoblastic cells
J Biomed Mater Res A Sun 65 290 2003 10.1002/jbm.a.10477 Human serum opsonization of orthopedic biomaterial particles: protein-binding and monocyte/macrophage activation in vitro
Bone Franchimont 37 601 2005 10.1016/j.bone.2005.06.002 Interleukin-6: an osteotropic factor influencing bone formation?
Exp Gerontol Lisignoli 39 659 2004 10.1016/j.exger.2003.09.030 IL1beta and TNFalpha differently modulate CXCL13 chemokine in stromal cells and osteoblasts isolated from osteoarthritis patients: evidence of changes associated to cell maturation
N Engl J Med Scott 355 704 2006 10.1056/NEJMct055183 Tumor necrosis factor inhibitors for rheumatoid arthritis
J Clin Invest Ammann 99 1699 1997 10.1172/JCI119333 Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrogen deficiency
Cell Micheau 114 181 2003 10.1016/S0092-8674(03)00521-X Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes
Am J Physiol Endocrinol Metab Gilbert 288 E1011 2005 10.1152/ajpendo.00534.2004 The p55 TNF receptor mediates TNF inhibition of osteoblast differentiation independently of apoptosis
Biochem Biophys Res Commun Shimada 390 775 2009 10.1016/j.bbrc.2009.10.048 Traf2 interacts with Smad4 and regulates BMP signaling pathway in MC3T3-E1 osteoblasts
Ann Rheum Dis Heiland 69 2152 2010 10.1136/ard.2010.132852 Neutralisation of Dkk-1 protects from systemic bone loss during inflammation and reduces sclerostin expression
Nature Harada 423 349 2003 10.1038/nature01660 Control of osteoblast function and regulation of bone mass
FASEB J Poole 19 1842 2005 10.1096/fj.05-4221fje Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation
J Bone Miner Res Stewart 14 1345 1999 10.1359/jbmr.1999.14.8.1345 Further characterization of cells expressing STRO-1 in cultures of adult human bone marrow stromal cells
J Bone Miner Res Quarles 7 683 1992 10.1002/jbmr.5650070613 Distinct proliferative and differentiated stages of murine MC3T3-E1 cells in culture: an in vitro model of osteoblast development
EMBO J Winkler 22 6267 2003 10.1093/emboj/cdg599 Osteocyte control of bone formation via sclerostin, a novel BMP antagonist
J Biol Chem Krause 285 41614 2010 10.1074/jbc.M110.153890 Distinct modes of inhibition by sclerostin on bone morphogenetic protein and Wnt signaling pathways
Int J Biochem Cell Biol Singhatanadgit 38 1794 2006 10.1016/j.biocel.2006.05.005 Bone morphogenetic protein receptors and bone morphogenetic protein signaling are controlled by tumor necrosis factor-alpha in human bone cells
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.